Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
Jasmina Varagic,1–3 Henry Punzi,4,5 Carlos M Ferrario2,3,61Hypertension and Vascular Research Center, 2Division of Surgical Sciences, 3Department of Physiology and Pharmacology, Wake Forest University, Winston-Salem, NC USA; 4Trinity Hypertension and Diagnostic Research Center, Carrollton,...
Saved in:
Main Authors: | Varagic J (Author), Punzi H (Author), Ferrario CM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
by: Vilela-Martin JF
Published: (2016) -
The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension
by: Doğan Erdoğan, et al.
Published: (2016) -
Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol-valsartan and nebivolol-lisinopril polytherapy in SHR rats
by: Lezama‐Martinez Diego, et al.
Published: (2024) -
Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
by: David T Nash, et al.
Published: (2009) -
Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study
by: Lee KJ, et al.
Published: (2023)